Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) Stock Information | RedChip

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) Listen to this Section


$2.91
-0.2100 ( -6.73% ) 3.9M

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Market Data


Open


$2.91

Previous close


$3.12

Volume


3.9M

Market cap


$124.17M

Day range


$2.75 - $3.48

52 week range


$2.75 - $11.41

Insider Ownership Transactions

Total Amount Purchased: -330,500.00 | $ -961,755.00

Date Type Amount Purchased Purchaser
2024-07-23 Sale -21649.00 Hayes Christopher G.
2024-07-23 Sale -18421.00 Goldenberg Gary
2024-07-23 Sale -25461.00 Bonaccorso Joe
2024-07-23 Sale -32469.00 White Ted
2024-06-07 Sale -20000.00 Eichenfield Lawrence
2024-06-07 Sale -20000.00 Ballaron Craig
2024-06-07 Sale -20000.00 Nguyen Diem
2024-06-07 Sale -20000.00 PRYGOCKI MARK A SR
2024-03-19 Sale -112500.00 White Ted
2024-03-19 Sale -40000.00 Hayes Christopher G.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 70 Aug 14, 2024
8-k 8K-related 75 Aug 14, 2024
8-k 8K-related 13 Aug 05, 2024
4 Insider transactions 1 Jul 23, 2024
4 Insider transactions 1 Jul 23, 2024
4 Insider transactions 1 Jul 23, 2024
4 Insider transactions 1 Jul 23, 2024
8-k 8K-related 13 Jun 28, 2024
8-k 8K-related 13 Jun 10, 2024
4 Insider transactions 1 Jun 07, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.